High-Specific-Activity-

3-Iodobenzylguanidine / therapeutic use Adrenal Gland Neoplasms / diagnostic imaging Humans Iodine Radioisotopes / therapeutic use Lutetium / therapeutic use Octreotide / analogs & derivatives Organometallic Compounds / therapeutic use Paraganglioma / diagnostic imaging Pheochromocytoma / diagnostic imaging Positron Emission Tomography Computed Tomography Radioisotopes / therapeutic use Radiopharmaceuticals / therapeutic use Radiotherapy / methods

Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 18 09 2020
revised: 14 11 2020
accepted: 03 03 2021
pubmed: 10 3 2021
medline: 22 3 2022
entrez: 9 3 2021
Statut: ppublish

Résumé

Targeted radionuclide therapies (TRT) using

Identifiants

DOI: 10.1158/1078-0432.CCR-20-3703 PMID: 33685867 PMC: PMC8172462
pubmed: 33685867
pii: 1078-0432.CCR-20-3703
doi: 10.1158/1078-0432.CCR-20-3703
pmc: PMC8172462
mid: NIHMS1683007
doi:

Substances chimiques

Iodine Radioisotopes 0
Iodine-131 0
Organometallic Compounds 0
Radioisotopes 0
Radiopharmaceuticals 0
3-Iodobenzylguanidine 35MRW7B4AD
Lutetium 5H0DOZ21UJ
lutetium Lu 177 dotatate AE221IM3BB
Lutetium-177 BRH40Y9V1Q
Octreotide RWM8CCW8GP

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2989-2995

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 HD008735
Pays : United States

Informations de copyright

©2021 American Association for Cancer Research.

Références

Curr Treat Options Oncol. 2020 Aug 29;21(11):85
pubmed: 32862332
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):934-946
pubmed: 31707430
Endocr Relat Cancer. 2019 Nov;26(11):R627-R652
pubmed: 31561209
J Surg Oncol. 2017 Mar;115(4):425-434
pubmed: 28166370
Clin Endocrinol (Oxf). 2019 Dec;91(6):718-727
pubmed: 31569282
EJNMMI Res. 2014 Dec;4(1):38
pubmed: 26116109
Clin Cancer Res. 2017 Aug 15;23(16):4617-4624
pubmed: 28428192
Cancer Biother Radiopharm. 2010 Jun;25(3):299-308
pubmed: 20578835
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3278-3287
pubmed: 28605448
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):476-489
pubmed: 27678267
Endocr Connect. 2020 Oct;9(9):864-873
pubmed: 32784267
J Clin Oncol. 2018 Sep 1;36(25):2578-2584
pubmed: 29878866
Cancers (Basel). 2019 Jun 28;11(7):
pubmed: 31261748
Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2372-2382
pubmed: 32123969
Nucl Med Mol Imaging. 2015 Sep;49(3):223-30
pubmed: 26279696
J Nucl Med. 2019 May;60(5):623-630
pubmed: 30291194
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Semin Nucl Med. 2016 May;46(3):203-14
pubmed: 27067501
Eur J Endocrinol. 2019 Jul;181(1):45-53
pubmed: 31067510
J Clin Endocrinol Metab. 2013 Oct;98(10):4006-12
pubmed: 23884775
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3296-3305
pubmed: 28605453

Auteurs

Abhishek Jha (A)

Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland.
ORCID: 0000-0002-1489-2471

David Taïeb (D)

Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.

Jorge A Carrasquillo (JA)

Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Radiology, Weill Cornell Medical College, New York, New York.
ORCID: 0000-0002-8513-5734

Daniel A Pryma (DA)

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Mayank Patel (M)

Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland.

Corina Millo (C)

Department of Positron Emission Tomography, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland.

Wouter W de Herder (WW)

Section of Endocrinology, Department of Internal Medicine, ENETS Centre of Excellence, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.
ORCID: 0000-0003-1463-5165

Jaydira Del Rivero (J)

Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.

Joakim Crona (J)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
ORCID: 0000-0003-0677-4894

Barry L Shulkin (BL)

Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee.
ORCID: 0000-0003-4784-7914

Irene Virgolini (I)

Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Alice P Chen (AP)

Division of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.
ORCID: 0000-0002-1426-853X

Bhagwant R Mittal (BR)

Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Sandip Basu (S)

Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Homi Bhabha National Institute, Mumbai, Maharashtra, India.

Joseph S Dillon (JS)

Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
ORCID: 0000-0002-4002-1418

Thomas A Hope (TA)

Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.

Carina Mari Aparici (C)

Divisions of Nuclear Medicine and Molecular Imaging, Stanford University School of Medicine, Stanford, California.

Andrei H Iagaru (AH)

Divisions of Nuclear Medicine and Molecular Imaging, Stanford University School of Medicine, Stanford, California.
ORCID: 0000-0003-0839-5329

Rodney J Hicks (RJ)

Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
ORCID: 0000-0002-0758-0824

Anca M Avram (AM)

Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan.
ORCID: 0000-0002-7940-9137

Jonathan R Strosberg (JR)

Division of Neuroendocrine Tumor/Department of Gastrointestinal Medicine, Moffitt Cancer Center, Tampa, Florida.

Ali Cahid Civelek (AC)

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Sciences, Johns Hopkins Medicine, Baltimore, Maryland.
ORCID: 0000-0003-4637-6292

Frank I Lin (FI)

Molecular Imaging Program, NCI, NIH, Bethesda, Maryland.

Neeta Pandit-Taskar (N)

Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York. karel@mail.nih.gov pandit-n@mskcc.org.
Department of Radiology, Weill Cornell Medical College, New York, New York.
ORCID: 0000-0003-1551-2036

Karel Pacak (K)

Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland. karel@mail.nih.gov pandit-n@mskcc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures halogénés › Hydrocarbures iodés › Iodobenzènes › 3-Iodobenzyl-guanidine › High-Specific-Activity-
questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs de la surrénale › High-Specific-Activity-
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › High-Specific-Activity-
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Radio-isotopes de l'iode › High-Specific-Activity-
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Terres rares › Lanthanides › Lutétium › High-Specific-Activity-
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Peptides cycliques › Octréotide › High-Specific-Activity-
questionsmedicales.fr › Composés chimiques organiques › Composés organométalliques › High-Specific-Activity-
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Paragangliome › High-Specific-Activity-
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Paragangliome › Phéochromocytome › High-Specific-Activity-
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › High-Specific-Activity-
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › High-Specific-Activity-
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › High-Specific-Activity-
questionsmedicales.fr › Thérapeutique › Radiothérapie › High-Specific-Activity-